您当前的位置：
首页 >
文章列表页 >
Analysis of clinical characteristics and risk factors for infection in patients with multiple myeloma treated with bortezomib
更新时间：2026-07-16

    • Analysis of clinical characteristics and risk factors for infection in patients with multiple myeloma treated with bortezomib

    • ZHONGGUO YAOFANG   Vol. 37, Issue 7, Pages: 942-948(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.07.20    

      CLC： R969.3;R979.1

    • Received：30 November 2025，

      Revised：2025-12-21，

      Accepted：18 March 2026，

      Published：15 April 2026

    移动端阅览

  • JIANG Wenting,ZHOU Jie,LYU Bo,et al.Analysis of clinical characteristics and risk factors for infection in patients with multiple myeloma treated with bortezomib[J].ZHONGGUO YAOFANG,2026,37(07):942-948. DOI： 10.6039/j.issn.1001-0408.2026.07.20.

  •  
  •  

0

Views

186

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of the incidence and associated factors of cyclosporine-associated acute kidney injury in hospitalized patients based on real-world data
Rapid health technology assessment of carfilzomib in the treatment of multiple myeloma
Real-world study on the application and influencing factors of SGLT-2i in patients with heart failure with preserved ejection fraction
Analysis of risk factors for serum digoxin concentration exceeding the warning threshold and construction of prediction model
Analysis of risk factors and construction of risk prediction model for batroxobin-related severe hypofibrinogenemia

Related Author

DOU Yaqing
LAO Jiahui
WANG Xue
SUN Yanying
HUANG Xin
LI Hanbing
LI Xiao
FENG Zhen

Related Institution

Healthcare Big Data Center， the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Dept. of Clinical Pharmacy， the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
College of Pharmaceutical Sciences， Zhejiang University of Technology
Dept. of Pharmacy， the Affiliated Hospital of Xuzhou Medical University
Dept. of Cardiology， Chongqing University Central Hospital
0